Linda Rydén1, Staffan Ahnve2, Max Bell3, Niklas Hammar4, Torbjörn Ivert5, Ulrik Sartipy5, Martin J Holzmann6. 1. Department of Anaesthesiology, Surgical Services and Intensive Care Medicine, Karolinska University Hospital, Stockholm, Sweden; Department of Internal Medicine, Karolinska Institutet, Stockholm, Sweden. Electronic address: Linda.ryden@karolinska.se. 2. Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden. 3. Department of Anaesthesiology, Surgical Services and Intensive Care Medicine, Karolinska University Hospital, Stockholm, Sweden; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden. 4. Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; AstraZeneca R&D, Mölndal, Sweden. 5. Department Cardiothoracic Surgery and Anaesthesiology, Karolinska University Hospital, Stockholm, Sweden; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. 6. Department of Internal Medicine, Karolinska Institutet, Stockholm, Sweden; Department of Emergency Medicine, Karolinska University Hospital, Sweden.
Abstract
BACKGROUND: Acute kidney injury (AKI) after coronary artery bypass grafting (CABG) is associated with early mortality. Its impact on the risk of myocardial infarction (MI) over time and long-term mortality has not been well described. METHODS: We performed a nationwide population-based cohort study in 27,929 patients who underwent a first isolated CABG between 2000 and 2008 in Sweden. Acute kidney injury was divided into three categories based on the absolute increase in postoperative serum creatinine (sCr) concentration compared with the preoperative baseline: stage 1, sCr increase of 0.3 to 0.5mg/dL; stage 2, sCr increase of >0.5 to 1.0mg/dL and stage 3, sCr increase of ≥ 1.0mg/dL. RESULTS: The overall incidence of postoperative AKI was 13%, 6.3% met the criterion for stage 1, 4.3% for stage 2 and 2.3% for stage 3. During a mean follow-up of 5.0 years, there were 2119 (7.6%) MIs and 4679 (17%) deaths. Multivariable adjusted hazard ratios with 95% confidence intervals for MI were 1.35 (1.15 to 1.57), 1.80 (1.53 to 2.13) and 1.63 (1.29 to 2.07), in AKI stages 1, 2 and 3, respectively. The corresponding hazard ratios for all-cause mortality were 1.30 (1.17 to 1.44), 1.65 (1.48 to 1.83) and 2.68 (2.37 to 3.03), respectively. CONCLUSIONS: Our results show that AKI after CABG is associated with an increased long-term risk of MI and death.
BACKGROUND:Acute kidney injury (AKI) after coronary artery bypass grafting (CABG) is associated with early mortality. Its impact on the risk of myocardial infarction (MI) over time and long-term mortality has not been well described. METHODS: We performed a nationwide population-based cohort study in 27,929 patients who underwent a first isolated CABG between 2000 and 2008 in Sweden. Acute kidney injury was divided into three categories based on the absolute increase in postoperative serum creatinine (sCr) concentration compared with the preoperative baseline: stage 1, sCr increase of 0.3 to 0.5mg/dL; stage 2, sCr increase of >0.5 to 1.0mg/dL and stage 3, sCr increase of ≥ 1.0mg/dL. RESULTS: The overall incidence of postoperative AKI was 13%, 6.3% met the criterion for stage 1, 4.3% for stage 2 and 2.3% for stage 3. During a mean follow-up of 5.0 years, there were 2119 (7.6%) MIs and 4679 (17%) deaths. Multivariable adjusted hazard ratios with 95% confidence intervals for MI were 1.35 (1.15 to 1.57), 1.80 (1.53 to 2.13) and 1.63 (1.29 to 2.07), in AKI stages 1, 2 and 3, respectively. The corresponding hazard ratios for all-cause mortality were 1.30 (1.17 to 1.44), 1.65 (1.48 to 1.83) and 2.68 (2.37 to 3.03), respectively. CONCLUSIONS: Our results show that AKI after CABG is associated with an increased long-term risk of MI and death.
Authors: Oliver K Jawitz; Brian C Gulack; J Matthew Brennan; Dylan P Thibault; Alice Wang; Sean M O'Brien; Jacob N Schroder; Jeffrey G Gaca; Peter K Smith Journal: Am Heart J Date: 2020-02-08 Impact factor: 4.749
Authors: Wim Vandenberghe; Sofie Gevaert; John A Kellum; Sean M Bagshaw; Harlinde Peperstraete; Ingrid Herck; Johan Decruyenaere; Eric A J Hoste Journal: Cardiorenal Med Date: 2015-12-19 Impact factor: 2.041
Authors: Alexander A Brescia; Xiaoting Wu; Gaetano Paone; Michael Heung; Theron A Paugh; Kenneth G Shann; David C Fitzgerald; Timothy A Dickinson; David Sturmer; Jeffrey Chores; Andrew L Pruitt; Haley Allgeyer; Sim Uppal; Min Zhang; Himanshu J Patel; Richard L Prager; Donald S Likosky Journal: J Thorac Cardiovasc Surg Date: 2019-03-29 Impact factor: 5.209
Authors: Ayodele Odutayo; Christopher X Wong; Michael Farkouh; Douglas G Altman; Sally Hopewell; Connor A Emdin; Benjamin H Hunn Journal: J Am Soc Nephrol Date: 2016-06-13 Impact factor: 10.121